Synthetic Data: A Real Fix for Clinical Trials?
The industry loves to celebrate synthetic data as a privacy solution—but where’s the real impact? Let’s be clear: privacy...
NeurOnos Secures $2M Funding for Innovative Autism Therapy
NeuroNOS, a Beyond Air subsidiary, secured $2 million in private equity funding to advance the preclinical development of a...
Alumis and Kaken Announce Licensing Agreement for Dermatology
Alumis and Kaken Pharmaceutical have partnered to develop and commercialize ESK-001, a selective TYK2 inhibitor, for dermatological conditions in...
Spark Biomedical: Neonatal Opioid Withdrawal Treatment Trial Enrollment Complete
Spark Biomedical has completed enrollment in its pivotal Phase II clinical trial for a non-invasive neurostimulation treatment for Neonatal...
Icovamenib Improves Pancreatic Beta-Cell Function in Diabetes Patients
Biomea Fusion announced preclinical and clinical data for its investigational menin inhibitor, icovamenib, at the ATTD 2025 Conference. The...
TN-201 Improves Cardiac Function & Survival in Cardiomyopathy Models
Tenaya Therapeutics announced positive preclinical data for TN-201, its gene therapy candidate for MYBPC3-associated hypertrophic cardiomyopathy (HCM), published in...
Study Reveals New Gene Variants Linked to Neural Tube Defects
Bionano Genomics and Greenwood Genetic Center (GGC) published a study in •Genome Research• demonstrating the use of optical genome...
Aquablation vs. Laser Enucleation: EAU Trial Results
PROCEPT BioRobotics announced positive three-month results from the WATER III trial, comparing its Aquablation therapy to laser enucleation for...
Clearside Biomedical Announces Six ARVO 2025 Abstracts
Clearside Biomedical announced the acceptance of six abstracts for presentation at the 2025 ARVO meeting. These abstracts cover topics...
Tonix Pharmaceuticals Advances NDA: TNX-102 SL for Fibromyalgia
Tonix Pharmaceuticals announced that the FDA will not require an advisory committee meeting for their New Drug Application (NDA)...